Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kaj Lahti"'
Autor:
Leif Groop, Johan G Eriksson, Niko S Wasenius, Tiinamaija Tuomi, Bo A Isomaa, Bjarne Östman, Johan Söderström, Björn Forsén, Kaj Lahti, Liisa Hakaste, Ola Hansson
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 2 (2020)
Introduction To investigate the effect of an exercise prescription and a 1-year supervised exercise intervention, and the modifying effect of the family history of type 2 diabetes (FH), on long-term cardiometabolic health.Research design and methods
Externí odkaz:
https://doaj.org/article/8800f1a0814c4d78be29152f1718fd0b
Autor:
Johan G. Eriksson, Kaj Lahti, Bjarne Östman, Liisa Hakaste, Björn Forsén, Tiinamaija Tuomi, Ola Hansson, Niko Wasenius, Leif Groop, Bo Isomaa, Johan Söderström
Publikováno v:
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, Vol 8, Iss 2 (2020)
BMJ Open Diabetes Research & Care, Vol 8, Iss 2 (2020)
IntroductionTo investigate the effect of an exercise prescription and a 1-year supervised exercise intervention, and the modifying effect of the family history of type 2 diabetes (FH), on long-term cardiometabolic health.Research design and methodsFo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80d70165aa7813297c84953cfd12902
http://hdl.handle.net/10138/324363
http://hdl.handle.net/10138/324363
Autor:
Tiinamaija Tuomi, Petter Vikman, Nael Shaat, Rashmi B. Prasad, Tom Forsén, Petter Storm, Mozhgan Dorkhan, Leif Groop, Annemari Käräjämäki, Kaj Lahti, Ylva Wessman, Anders Rosengren, Åke Lernmark, Annelie Carlsson, Ola Hansson, Ulf Malmqvist, Mats Martinell, Hindrik Mulder, Emma Ahlqvist, Eero Lindholm, Dina Mansour Aly, Peter Almgren, Peter Spégel, Olle Melander
Publikováno v:
The Lancet Diabetes & Endocrinology
Summary Background Diabetes is presently classified into two main forms, type 1 and type 2 diabetes, but type 2 diabetes in particular is highly heterogeneous. A refined classification could provide a powerful tool to individualise treatment regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b53c46bf688c76057b9c23f12b91c9
Autor:
Dina Mansour Aly, Anders Rosengren, Petter Vikman, Hindrik Mulder, Åke Lernmark, Ola Hansson, Peter Spégel, Eero Lindholm, Tom Forsén, Leif Groop, Emma Ahlqvist, Mozhgan Dorkhan, Peter Almgren, Petter Storm, Olle Melander, Rashmi B. Prasad, Kaj Lahti, Nael Shaat, Ylva Wessman, Annelie Carlsson, Tiinamaija Tuomi, Annemarie Käräjämäki, Ulf Malmqvist, Mats Martinell
BackgroundDiabetes is presently classified into two main forms, type 1 (T1D) and type 2 diabetes (T2D), but especially T2D is highly heterogeneous. A refined classification could provide a powerful tool individualize treatment regimes and identify in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756ed46cda2383bdbeb560c73ab69403
Autor:
Carol Forsblom, Mette K. Andersen, Peter M. Nilsson, Per-Henrik Groop, Olov Rolandsson, Annemari Käräjämäki, Tiinamaija Tuomi, Tom Forsén, Leif Groop, Maria Sterner, Kaj Lahti
Publikováno v:
Diabetologia
Latent autoimmune diabetes in adults (LADA) is phenotypically a hybrid of type 1 and type 2 diabetes. Genetically LADA is poorly characterised but does share genetic predisposition with type 1 diabetes. We aimed to improve the genetic characterisatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51675f1826fb8fd38611a7a13c79499
https://doi.org/10.1007/s00125-014-3287-8
https://doi.org/10.1007/s00125-014-3287-8
Autor:
Tiinamaija Tuomi, Marja-Riitta Taskinen, Michael Nissén, Bo Isomaa, Björn Forsén, Leif Groop, Kaj Lahti, Peter Almgren
Publikováno v:
University of Helsinki
OBJECTIVE—To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization (WHO). RESEARCH DESIGN AND METHODS—A total of 4,483 subjects aged 35–7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5d88697b26e2752418f81da4839e0e
https://doi.org/10.2337/diacare.24.4.683
https://doi.org/10.2337/diacare.24.4.683
Autor:
Anita Nilsson, Kaj Lahti, Björn Forsén, Leif Groop, Bo Isomaa, A. Carlsson, B. Snickars, Tiinamaija Tuomi, Carola Saloranta, Haiyan Li, B.-O. Ehrnström, Marja-Riitta Taskinen, Michael Nissén, Aaro Miettinen, Carol Forsblom
Publikováno v:
University of Helsinki
The aim of the study was 1) to establish the prevalence of GAD antibodies (GADab) in a population-based study of type 2 diabetes in western Finland, 2) to genetically and phenotypically characterize this subgroup, and 3) to provide a definition for l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69433876c37c209c8d12647fd768836
https://doi.org/10.2337/diabetes.48.1.150
https://doi.org/10.2337/diabetes.48.1.150
Autor:
Kaj Lahti, N. Holmstrom, Björn Forsén, O. Matintupa, Peter Almgren, Valeriya Lyssenko, Leif Groop, Johan Wadén, Tiinamaija Tuomi, Bo Isomaa, Marja-Riitta Taskinen, Johan G. Eriksson
Publikováno v:
Diabetologia. 53(8)
We studied the impact of a family history of type 2 diabetes on physical fitness, lifestyle factors and diabetes-related metabolic factors.The Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study is a population-based study in Western
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99ae3942d5166b8f37aacaf176c762db
https://pubmed.ncbi.nlm.nih.gov/20454776
https://pubmed.ncbi.nlm.nih.gov/20454776
Autor:
Roland Perfekt, Dragi Anevski, Marja-Riitta Taskinen, Michael Nissén, Bo Isomaa, Kaj Lahti, Leif Groop, Valeriya Lyssenko, Björn Forsén, Tiinamaija Tuomi, Nils Homström, Carola Saloranta, Peter Almgren
Publikováno v:
University of Helsinki
Identification of individuals at high risk of developing type 2 diabetes is a prerequisite for prevention of the disease. We therefore studied risk factors predicting type 2 diabetes in the Botnia Study in western Finland. A total of 2,115 nondiabeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef94d785e857fe53225580569c12ee4
https://pubmed.ncbi.nlm.nih.gov/15616025
https://pubmed.ncbi.nlm.nih.gov/15616025
Autor:
Pedro de Pablos-Velasco, Christiane Guitard, Eckhard Pecher, Carola Saloranta, Leif Groop, Patrick Brunel, Kaj Lahti
Publikováno v:
Diabetes care. 25(12)
OBJECTIVE—The purpose of this study was to evaluate the metabolic effectiveness, safety, and tolerability of nateglinide in subjects with impaired glucose tolerance (IGT) and to identify a dose appropriate for use in a diabetes prevention study. RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb2bc0efb35d6f7445567ebae28db36
https://pubmed.ncbi.nlm.nih.gov/12453951
https://pubmed.ncbi.nlm.nih.gov/12453951